Investors

Predictive Technology Group, Inc.

Business Description

Predictive Technology Group, Inc. (PRED) through its wholly owned subsidiary Predictive Therapeutics, Inc. revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression. PRED uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.

Stock

 

 

FINANCIAL REPORTING/DISCLOSURE

Reporting Status Alternative Reporting Standard
Deregistered a/o Jan 04, 2011
Audited Financials Unaudited
Latest Report Nov 30, 2015 Quarterly Report
CIK 0001382943
Fiscal Year End 8/31
OTC Marketplace OTC Pink Current

 

PROFILE DATA

SIC – Industry Classification 2835 – Diagnostic substances
Business Status Development Stage Company a/o Sep 16, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees 10 a/o Jun 05, 2015

 

COMPANY OFFICERS/CONTACTS

Merle Ferguson Secretary, Treasurer
Bradley Robinson President

 

COMPANY DIRECTORS

Merle Ferguson Chairman
Bradley Robinson Director

SERVICE PROVIDERS

ACCOUNTING/AUDITING FIRM

  • CS&S Enterprises
  • 5840 West Craig Road,
    Las Vegas, NV, 89130
    United States

LEGAL COUNSEL

  • Law Office of Robert W. Wright
  • 716 Castro St.,
    Solana Beach, CA, 92075
    United States

INVESTOR RELATIONS

CONTACT INFO